BiotechTube
Home/Evommune/Kyle Carver
KC

Kyle Carver

Chief Financial Officer

Evommune

Therapeutic Areas

ImmunologyDermatologyGastroenterologyNeurology

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2

Leadership Team at Evommune

LP
Luis Peña
President & Chief Executive Officer
EA
Eugene A. Bauer
Chief Medical Officer
GS
Gregory S. Moss
Chief Business and Legal Officer
JP
Jeegar Patel
Chief Scientific Officer
BF
Benjamin F. McGraw, III
Chair of the Board
View full Evommune profile